JGJoan Guitart

Joan Guitart

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Joan Guitart has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • ‘Eruptive syringoma’: a misnomer for a reactive eccrine gland ductal proliferation?

    by J. Guitart, M. M. Rosenbaum, L. Requena

    Background:  Syringomas have traditionally been categorized as benign neoplasms of the eccrine gland ductal epithelium. However, the variety of clinical presentations reported in the literature and some cases recently observed by the authors cast doubt upon the neoplastic nature of eruptive syringomas. Our goal is to challenge the traditional notion that eruptive syringomas are neoplastic lesions.Results:  We observed two patients who presented with an eczematous process, which resolved leaving residual lesions. Biopsies of the late lesions showed features of eccrine syringoma. Yet a biopsy obtained from an incipient lesion in one of the cases showed a lymphocytic inflammatory reaction of the superficial portion of the eccrine duct resulting in tortuous hyperplastic changes.Conclusion:  Based on our observations, some of the so‐called ‘eruptive syringoma’ may represent a hyperplastic response of the eccrine duct to an inflammatory reaction rather than a true adnexal neoplasm. We proposed the term ‘syringomatous dermatitis’ for such cases.


  • Open Access

    Histological Characteristics of Metastasizing Thin Melanomas

    by Joan Guitart, Lori Lowe, Michael Piepkorn, Victor G. Prieto, Michael S. Rabkin, Salve G. Ronan, Christopher R. Shea, Victor A. Tron, Wain White, Raymond L. Barnhill

    MICROSCOPIC assessment of Breslow thickness is the most accurate prognostic indicator in malignant melanoma.1 There is ample evidence that tumor thickness is directly proportional to the development of metastasis and to the overall patient survival.2 In general, melanomas with a Breslow thickness of less than 1 mm have a good prognosis, with a low incidence of metastasis. However, thin melanomas may develop metastasis.3-12 We have reviewed our experience with metastasizing melanomas with a Breslow thickness of less than 1 mm. Our goal was to identify those clinical and histological factors that may predict a subset of thin melanomas more likely to metastasize.


  • Histologic criteria for the diagnosis of mycosis fungoides: proposal for a grading system to standardize pathology reporting

    by Joan Guitart, John Kennedy, Salve Ronan, Joan S. Chmiel, Yi‐Ching Hsiegh, Daina Variakojis

    Background: The histological diagnosis of early lesions of mycosis fungoides (MF) is often difficult for dermatopathologists and prior studies have shown a low agreement rate among pathologists. An important reason for such difficulty may be the lack of specific histological criteria.Methods: We tested a new method to interpret and report biopsies suspicious for MF. The method is based on a grading system reflecting the pathologist’s degree of diagnostic certainty. A panel of four pathologists independently assessed a set of 50 biopsies suspicious for MF first without (Phase I) and subsequently with specific histological criteria (Phase II). A third Phase was carried out after a training session, using a new set of cases with corresponding immunophenotyping and gene rearrangement analysis. Weighted and unweighted kappa statistics were used to assess inter‐ and intra‐pathologist variation.Results: The consensus rate among pathologists improved from 48% in Phase I to 76% in Phase III. Overall precision weighted kappas increased from 0.630 in Phase I to 0.854 in Phase III, indicating excellent inter‐pathologist agreement by Phase III. There was a significant association between the presence of an abnormal phenotype and/or T‐cell clonality and a higher diagnostic score.Conclusions: The use of uniform criteria and training sessions can substantially improve the consensus rate among pathologists in the diagnosis of MF.